Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.50 0.40 0.55 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 3.2 -1.5 - 3

Motif Bio Share Discussion Threads

Showing 8801 to 8825 of 9100 messages
Chat Pages: 364  363  362  361  360  359  358  357  356  355  354  353  Older
DateSubjectAuthorDiscuss
23/12/2020
13:21
AGM’s are what these cowards call when they don’t have to go face to face with the investors whom they have lost so much money for They could easily have done a Zoom AGM and last year Lumsden could have done the AGM post the FDA decision but like the ‘leader’ he is pulled it forward so he didn’t have to face the music. Says everything about him sadly
scottdavid70
23/12/2020
13:19
Someone please tell Robblertwo it’s a General Meeting he needs to call not a AGM. They need to take him seriously from the first time he contacts them
scottdavid70
23/12/2020
13:15
Good piece of work to all concerned.
smcl
23/12/2020
13:10
Certainly apathy wont make the Directors do the right thing - they have taken investors as idiots these past 2 years and treated them with virtual contempt.
scottdavid70
23/12/2020
12:59
Love at bit of activism personally - this BOD has fundamentally let down investors for 2 years and it’s about time ordinary men abs women who have invested here off the back of the BOD’s proclamations answer the questions they have tried to dodge pathetically for 2 years
scottdavid70
23/12/2020
12:51
Thanks Chuffer - someone Let Robblertwo know everyone that he has all the shares he needs to force the General meeting and plenty in reserve
scottdavid70
23/12/2020
12:40
They can add my 19 million for what it's worth
chuffer2
23/12/2020
12:27
I see someone having a pop on Twitter at Walbrook and Motif for not answering emails etc
scottdavid70
23/12/2020
12:27
He should contact the company and tell them what he is proposing - making they will grow a conscience and do the right thing for once in 2 years
scottdavid70
23/12/2020
12:26
Robblertwo will find we are closer to 10% by the time everyone’s are counted up
scottdavid70
23/12/2020
12:11
Good to see a rebellion on LSE happening finally - certainly more backbone that Lumsden
scottdavid70
23/12/2020
10:49
Robblertwo on LSE I can guarantee you 17 million for you call for general meeting between a few of my friends and myself
scottdavid70
23/12/2020
09:28
Seasons greetings to Walbrook, Peel Hunt, Graham Lumsden, Jon Gold, Bruce Williams and Chris Wardhaugh Hope your families know what your work principles are that have allowed them to enjoy the lavish lifestyle you enjoy this festive season
scottdavid70
23/12/2020
09:25
Simple question why was Peel Hunt brought in if there was no deal worth doing at that stage apart from making more fees from the last bit of the Motif carcass?
scottdavid70
23/12/2020
09:24
I see from LSE the Board are still actively looking for RTO candidates. Basically that means we will pay the current Board their money next month as their are still “active” and then Graham will take his last wedge and Gold his last bit of the unearned $325,000 this past year and swan off into the sunset. Clueless and conscious less the entire Board, associated companies and brokers
scottdavid70
23/12/2020
05:21
In answer to Robblertwo question on LSE yes is the answer. We do hold enough shares to call a General Meeting. Graham however isn’t fond of talking to the people who have funded his lifestyle but happy to put my shares and others I know on here whom have more than enough to call it if you want to arrange. Walbrook should be happy to organise they need to do something to earn their corn here as they have no Proactive interviews to set up for Motif which is basically all they do as a PR group for their fees
scottdavid70
22/12/2020
21:00
It’s also why I believe that unless Lumsden address clearly and concisely what’s gone on here from the time time Of the CRL he should never sit on a BoD again and as the worst CEO in history in my humble opinion never do that job again. He still wants a BONUS even after all of that and what he has put investors through. Zero shame
scottdavid70
22/12/2020
20:43
I goess the thing that is most central to my book is the theme of saying one thing and then it not happening such as: NDA submission late - one shot at goal? Or was it then that the liver issue was known that made them have liver experts on standby for the FDA? EMA submission in - quirky pulled with no RNS just slipped in a investor presentation Same with the HABP trials Then the no clinical trials Then the all bases covered Then the moving of the AGM to before the FDA decision Then the Iclaprim tie up with Lamellar and news in a few months - still nothing Full phase 3 trials and several years - huge funding and so reclassified as a shell company- vote needed otherwise company goes under - sound like all bases covered when on that type of knife edge? US Army trials announced to much fanfare - still nothing Strategic business partner for several Covid therapeutic companies- still no deal Fully funded till Feb 2021 - interims state significant dilution possible again for investors- why? Samdoz new patents for Iclaprim- we aren’t told anything Strict cost controls 2019 - almost US $1.1 million for two directors in 2019 Nasdaq needed for company to grow - sucked in too much cash for extra regulations - delist - vanity project for Graham most of us now think No Board reviews last year after a catastrophic year - why? Not good Corporate Governance Opaque RNS - several term sheets agreed yet still searching for a suitable a RTO. What exactly does that mean? The ones at Term Sheets aren’t good enough? Investors deserve better by their Directors than this mini resume of what’s gone on here
scottdavid70
22/12/2020
19:52
Scammed...
scottdavid70
22/12/2020
18:55
On top of that we need a prospectus, a vote and a RTO done by the 28th January. Zero change that happens Gold just going to take his last $25,000 in January and run away as they all have ultimately
scottdavid70
22/12/2020
18:54
Laughable how they feel we have fallen for their ruse about 40 companies and several at term sheet stage but the “search goes on for a suitable RTO” ok if the term sheets were needing to be negotiated it would shave been done a month ago so clearly they had fallen away otherwise why say the search goes on. Just trying to ale themselves look adequate at best but failing miserably
scottdavid70
22/12/2020
14:06
To be fair the no clinical trails comment on the WebCast of the 19th February 2019 that ended up being another full phase 3 trail costing $40 Million and 3.5 years is how did that part it...disingenuous at best:-)
scottdavid70
22/12/2020
13:40
The main thrust of the story for them is the strict cost controls supposedly Motif was under in 2019 and the almost US $1.1 MILLION two Director’s took home along with a few pensionable benefits and are THEN IN LINE FOR A BONUS AND A HUGE AMOUNT IN DEFERRED PAYMENTS. This draining affect in terms of dilution through unnecessary fund raises has brought the Board of Directors culpable for these vast sums to be paid out sharply into focus along with the affiliated companies involved such as Walbrook and Peel Hunt. Reputation damage here is simply immense. That is simply unpalatable to them in these horrendous times for ordinary investors caught up in the Machiavellian spin that has unfolded here
scottdavid70
22/12/2020
13:20
Holding people accountable is extremely en bouvier at these difficult times. Certainly this story is resonating with a lot of different media outlets
scottdavid70
22/12/2020
12:22
Walbrook Northland Capital Peel Hunt X 100 Zacks Motif Bio all Board Members past and current SP Angel
scottdavid70
Chat Pages: 364  363  362  361  360  359  358  357  356  355  354  353  Older
ADVFN Advertorial
Your Recent History
LSE
MTFB
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210225 11:33:46